Supportive Care

Anne Katz, from the University of Manitoba, Discusses Cancer and Sexuality

Kim Kelly, from John Theurer Cancer Center, on the Updated MASCC/ISOO Clinical Practice Guidelines for Mucositis

Cancer pain management has greatly improved with advances in oral and intravenous medication. However, several challenges still exist in administration.

Thanks to earlier detection and improved treatment, the population of cancer survivors has increased dramatically and will continue to increase as the baby boomers age.

Patients who undergo chemotherapy for breast cancer may develop fatigue that remains problematic long after they complete treatment.

Complementary! Sounds good, how could it hurt? When applied in cancer therapy, however, what sounds good may not always be good for patients.

Dr. Nancy Davidson, from the University of Pittsburgh Cancer Institute, Discusses Breast Cancer Chemoprevention

New data show that roughly one-fifth of tamoxifen-treated male patients with breast cancer stop treatment early because of side effects.

Outpatient management in patients with cancer who have a low risk of severe febrile neutropenia is an effective and safe option to standard inpatient treatment.

Supportive care is a crucial component of personalized oncology care.

Patients with metastatic breast cancer who were treated with eribulin mesylate were less likely to experience peripheral neuropathy.

Patients who receive a solid organ transplant have about twice the risk of developing cancer as the general population.

Radiotherapy often results in the loss of some salivary gland function, causing hyposalivation and xerostomia.

Cancer treatment addresses a patient's physical health but the mental state of the patient is something that might need more than an oncologist's expertise.

Antiresorptive medicines used to reduce the loss of bone mass related to bone metastases or treatment toxicity are associated with an increased risk of ONJ.

Parents prefer palliative chemotherapy for their child with cancer who is not expected to survive, while healthcare workers favor supportive care.

As cancer treatments become more personalized, patients will be faced with learning complex biological concepts if they want to understand their tumors -- and their choices.

Dr. Linda Vahdat, from the New York-Presbyterian Hospital, Compares Halaven and Ixempra Neuropathy

Researchers are urging oncologists to improve the communication of complex medical information to their patients.

Dr. Wayne Bardwell from UCSD Cancer Center Expresses the Importance of Listening

Dr. Kenneth Fleisher from NYU College of Dentistry Explains How Nurses Can Identify osteonecrosis of the jaw.

A panel released guidelines to help clinicians identify patients experiencing cancer-related pain who would benefit from an implanted intrathecal (IT) drug delivery systems.

ASCO endorses a Canadian agency's outlook on ovarian ablation, chemotherapy limits for stage IV lung cancer patients, and supportive care antiemetic therapies.

Dr. Teresa Woodruff from Feinberg School of Medicine, Northwestern University, Discusses Oncofertility Insurance Coverage

The number of cancer survivors in the United States has quadrupled since 1971, making it imperative for healthcare professionals to identify and address the needs of this burgeoning population.